{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:45:18Z","timestamp":1786985118338,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03964"],"award-info":[{"award-number":["22H03964"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K25218"],"award-info":[{"award-number":["23K25218"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004496","name":"National Institute for Materials Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009757","name":"National Institute of Advanced Industrial Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006134","name":"Foundation for Promotion of Material Science and Technology of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioadv.2025.214565","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:27:08Z","timestamp":1760855228000},"page":"214565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Radiosensitizing in situ cancer vaccines combined with immune checkpoint blockade to overcome resistance to radioimmunotherapy"],"prefix":"10.1016","volume":"180","author":[{"given":"Xiupeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioadv.2025.214565_bb0005","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/S1470-2045(24)00407-8","article-title":"Radiotherapy and theranostics: a Commission","volume":"25","author":"Abdel-Wahab","year":"2024","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.bioadv.2025.214565_bb0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S1470-2045(15)00285-5","article-title":"Global task force on radiotherapy for cancer control","volume":"16","author":"Jaffray","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioadv.2025.214565_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2020.12.045","article-title":"Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity","volume":"502","author":"Donlon","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214565_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bioadv.2025.214565_bb0025","article-title":"Cellular stress responses in radiotherapy","volume":"8","author":"Kim","year":"2019","journal-title":"Cells-Basel"},{"key":"10.1016\/j.bioadv.2025.214565_bb0030","doi-asserted-by":"crossref","first-page":"1158198","DOI":"10.3389\/fchem.2023.1158198","article-title":"Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases","volume":"11","author":"Chaudhary","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioadv.2025.214565_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107386","article-title":"Chiral inorganic nanomaterials in the tumor microenvironment: a new chapter in cancer therapy","volume":"208","author":"Song","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"24","key":"10.1016\/j.bioadv.2025.214565_bb0040","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1039\/D0BM01738H","article-title":"Mesoporous silica integrated with FeO and palmitoyl ascorbate as a new nano-fenton reactor for amplified tumor oxidation therapy","volume":"8","author":"Sun","year":"2020","journal-title":"Biomater Sci-Uk"},{"issue":"305","key":"10.1016\/j.bioadv.2025.214565_bb0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation - radiobiology or medicine","volume":"26","author":"Mole","year":"1953","journal-title":"Brit J Radiol"},{"issue":"10","key":"10.1016\/j.bioadv.2025.214565_bb0050","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/cancers15102751","article-title":"Novel drugs and radiotherapy in relapsed lymphomas: abscopal response and beyond","volume":"15","author":"Perrone","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.bioadv.2025.214565_bb0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6230","key":"10.1016\/j.bioadv.2025.214565_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bioadv.2025.214565_bb0065","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.bioadv.2025.214565_bb0070","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bioadv.2025.214565_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","article-title":"Safety of combining radiotherapy with immune-checkpoint inhibition","volume":"15","author":"Hwang","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioadv.2025.214565_bb0080","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1016\/S1470-2045(24)00075-5","article-title":"Radiotherapy, immunity, and immune checkpoint inhibitors","volume":"25","author":"Lynch","year":"2024","journal-title":"Lancet Oncol."},{"issue":"100","key":"10.1016\/j.bioadv.2025.214565_bb0085","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.1039\/C4CC06064D","article-title":"Sub-20 nm-Fe3O4 square and circular nanoplates: synthesis and facet-dependent magnetic and electrochemical properties","volume":"50","author":"Luo","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214565_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/thno.64862","article-title":"A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy","volume":"12","author":"Jiang","year":"2022","journal-title":"Theranostics"},{"issue":"1\u20133","key":"10.1016\/j.bioadv.2025.214565_bb0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.micromeso.2010.01.009","article-title":"The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid","volume":"131","author":"He","year":"2010","journal-title":"Microporous Mesoporous Mater."},{"issue":"16","key":"10.1016\/j.bioadv.2025.214565_bb0100","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214565_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/nnm.11.166","article-title":"Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage","volume":"7","author":"Rosenholm","year":"2012","journal-title":"Nanomedicine-Uk"},{"issue":"11","key":"10.1016\/j.bioadv.2025.214565_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081346","article-title":"Structural Determinants for Protein adsorption\/non-adsorption to Silica Surface","volume":"8","author":"Mathe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2025.214565_bb0115","article-title":"Aminated hollow mesoporous silica nanoparticles as an enhanced loading and sustained releasing carrier for doxorubicin delivery","volume":"309","author":"Thi","year":"2020","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.bioadv.2025.214565_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.32933\/ActaInnovations.26.5","article-title":"Decomposition of hydrogen perodixe - kinetics and review of chosen catalysts","volume":"26","author":"P\u0119dziwiatr","year":"2018","journal-title":"Acta Innov."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214565_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802244","article-title":"Emerging strategies of nanomaterial-mediated tumor radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv. Mater."},{"issue":"23","key":"10.1016\/j.bioadv.2025.214565_bb0130","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1039\/D1CS01145F","article-title":"Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection","volume":"51","author":"Pan","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.bioadv.2025.214565_bb0135","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1021\/cr300358b","article-title":"Disulfide-cleavage-triggered chemosensors and their biological applications","volume":"113","author":"Lee","year":"2013","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214565_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13014-023-02275-8","article-title":"Radio-resistance of hypoxic tumors: exploring the effects of oxygen and x-ray radiation on non-small lung cancer cell lines","volume":"18","author":"Hanley","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bioadv.2025.214565_bb0145","doi-asserted-by":"crossref","first-page":"5047987","DOI":"10.1155\/2020\/5047987","article-title":"ROS-mediated therapeutic strategy in chemo\u2212\/radiotherapy of head and neck cancer","volume":"2020","author":"Huang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214565_bb0150","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1523-1755.2005.00598.x","article-title":"The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients","volume":"68","author":"Spinowitz","year":"2005","journal-title":"Kidney Int."},{"issue":"13","key":"10.1016\/j.bioadv.2025.214565_bb0155","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/1078-0432.CCR-19-3642","article-title":"Intratumoral Immunotherapy for Early-stage Solid Tumors","volume":"26","author":"Hong","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bioadv.2025.214565_bb0160","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S1470-2045(19)30326-2","article-title":"NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial","volume":"20","author":"Bonvalot","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214565_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/02656736.2020.1810333","article-title":"vaccination with nanoparticles for cancer immunotherapy: understanding the immunology","volume":"37","author":"Mao","year":"2020","journal-title":"Int. J. Hyperth."},{"issue":"38","key":"10.1016\/j.bioadv.2025.214565_bb0170","doi-asserted-by":"crossref","first-page":"1701816","DOI":"10.1002\/smll.201701816","article-title":"Hollow ZnO nanospheres enhance anticancer immunity by promoting CD4+ and CD8+ T cell populations in vivo","volume":"13","author":"Wang","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2025.214565_bb0175","doi-asserted-by":"crossref","first-page":"43538","DOI":"10.1021\/acsami.7b16118","article-title":"Biodegradable Metal Ion-Doped Mesoporous Silica Nanospheres Stimulate Anticancer Th1 Immune Response in Vivo","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"13","key":"10.1016\/j.bioadv.2025.214565_bb0180","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1039\/C8CS00028J","article-title":"Tailoring inorganic nanoadjuvants towards next-generation vaccines","volume":"47","author":"Li","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214565_bb0185","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/anie.201506179","article-title":"Stimulation of in vivo antitumor immunity with hollow mesoporous silica nanospheres","volume":"55","author":"Wang","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"13","key":"10.1016\/j.bioadv.2025.214565_bb0190","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/smll.201102620","article-title":"Adjuvant properties of mesoporous silica particles tune the development of effector T cells","volume":"8","author":"Vallhov","year":"2012","journal-title":"Small"},{"issue":"50","key":"10.1016\/j.bioadv.2025.214565_bb0195","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1016\/j.vaccine.2010.09.087","article-title":"Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15","volume":"28","author":"Carvalho","year":"2010","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.bioadv.2025.214565_bb0200","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1002\/adma.201400815","article-title":"Monodispersed and Ordered Large-Pore Mesoporous Silica Nanospheres with Tunable Pore Structure for Magnetic Functionalization and Gene Delivery","volume":"26","author":"Niu","year":"2014","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.bioadv.2025.214565_bb0205","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1002\/smll.201600677","article-title":"Hollow structure improved anti-cancer immunity of mesoporous silica nanospheres in vivo","volume":"12","author":"Wang","year":"2016","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214565_bb0210","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1038\/s41467-020-17637-z","article-title":"A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214565_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/pr.2016.71","article-title":"The TLR-specific adjuvants R-848 and CpG-B endorse the immunological reaction of neonatal antigen-presenting cells","volume":"80","author":"Schuller","year":"2016","journal-title":"Pediatr. Res."},{"issue":"11","key":"10.1016\/j.bioadv.2025.214565_bb0220","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"16","key":"10.1016\/j.bioadv.2025.214565_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164908","article-title":"Myeloid-derived suppressor cells: new insights into the pathogenesis and therapy of MDS","volume":"11","author":"Velegraki","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214565_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12441","article-title":"Anti-cancer therapy with TNF\u03b1 and IFN\u03b3: a comprehensive review","volume":"51","author":"Shen","year":"2018","journal-title":"Cell Proliferat"},{"key":"10.1016\/j.bioadv.2025.214565_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mattod.2023.06.001","article-title":"Nanoengineered coordination polymers boost cancer immunotherapy","volume":"67","author":"Li","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.bioadv.2025.214565_bb0240","article-title":"Inosine pranobex-derived coordination complexes for self-adjuvant, self-carrier, and self-assembled vaccines in cancer immunotherapy","volume":"39","author":"Li","year":"2024","journal-title":"Appl. Mater. Today"},{"issue":"6","key":"10.1016\/j.bioadv.2025.214565_bb0245","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/vaccines12060649","article-title":"Synergistic effects of metal-organic nanoplatform and guanine quadruplex-based CpG oligodeoxynucleotides in therapeutic cancer vaccines with different tumor antigens","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.bioadv.2025.214565_bb0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/cancers8030036","article-title":"Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy","volume":"8","author":"Golubovskaya","year":"2016","journal-title":"Cancers"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:57:02Z","timestamp":1773817022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825003929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"alternative-id":["S2772950825003929"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214565","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosensitizing in situ cancer vaccines combined with immune checkpoint blockade to overcome resistance to radioimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214565"}}